X-37: AI-Enabled Drug Discovery Company X-37 Announces $14.5 Million In Funding
Enabled drug discovery company X-37 announced it closed $14.5 million in Series A funding led by DCVC Bio.The post AI-Enabled Drug Discovery Company X-37 Announces $14.5 Million In Funding appeared first on Pulse 2.0.
Read full article »
X-37 is an artificial intelligence-enabled drug discovery company that develops molecules for the treatment of cancer and tumor.
Read more